Mario Stylianou

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi Joint analysis of case-parents trio and unrelated case-control designs in large scale association studies
    Jungnam Joo
    Office of Biostatistics Research, National Heart, Lung and Blood Institute, 6701 Rockledge Drive, MSC 7913, Bethesda, MD 20892 7913, USA
    BMC Proc 1:S28. 2007
  2. ncbi Dose finding using the biased coin up-and-down design and isotonic regression
    Mario Stylianou
    Office of Biostatistics Research, National Heart, Lung, and Blood Institute, Bethesda, Maryland 20892, USA
    Biometrics 58:171-7. 2002
  3. ncbi Estimating the probability of toxicity at the target dose following an up-and-down design
    Mario Stylianou
    Office of Biostatistics Research, National Heart, Lung, and Blood Institute NIH, 6701 Rockledge Drive, Room 8220, Bethesda, MD 20892, U S A
    Stat Med 22:535-43. 2003
  4. ncbi The accelerated biased coin up-and-down design in phase I trials
    Mario Stylianou
    Office of Biostatistics Research, NHLBI, Bethesda, Maryland 20892 7938, USA
    J Biopharm Stat 14:249-60. 2004
  5. ncbi Robust ranks of true associations in genome-wide case-control association studies
    Gang Zheng
    Office of Biostatistics Research, National Heart, Lung and Blood Institute, 6701 Rockledge Drive, MSC 7938, Bethesda, Maryland 20892 USA
    BMC Proc 1:S165. 2007
  6. ncbi Reversible airflow obstruction in lymphangioleiomyomatosis
    Angelo M Taveira-Dasilva
    Translational Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892 1590, USA
    Chest 136:1596-603. 2009
  7. ncbi Erythropoietin-driven proliferation of cells with mutations in the tumor suppressor gene TSC2
    Yoshihiko Ikeda
    National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892 1590, USA
    Am J Physiol Lung Cell Mol Physiol 300:L64-72. 2011
  8. ncbi Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus
    Angelo M Taveira-Dasilva
    Cardiovascular and Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892 1590, USA
    Ann Intern Med 154:797-805, W-292-3. 2011
  9. ncbi Examination of lower targets for low-density lipoprotein cholesterol and blood pressure in diabetes--the Stop Atherosclerosis in Native Diabetics Study (SANDS)
    Marie Russell
    Phoenix Indian Medical Center, Phoenix, AZ, USA
    Am Heart J 152:867-75. 2006

Collaborators

  • Jungnam Joo
  • Michael Proschan
  • Xin Tian
  • D A Follmann
  • Angelo M Taveira-Dasilva
  • Joel Moss
  • Yoshihiko Ikeda
  • Olanda Hathaway
  • Wendy K Steagall
  • Gang Zheng
  • Marie Russell
  • Gustavo Pacheco-Rodriguez
  • Bernadette R Gochuico
  • Rose M May
  • Shaowei Li
  • Thomas N Darling
  • Olanda M Hathaway
  • Souheil El-Chemaly
  • Ji An Wang
  • Roberto Cassandro
  • Antoinette Rabel
  • Sergio Harari
  • Nancy L Geller
  • Myron A Waclawiw
  • Jing Ping Lin
  • Jeffrey A Henderson
  • Wm James Galloway
  • Robert E Ratner
  • Jianhui Zhu
  • Fawn Yeh
  • Elisa T Lee
  • James Howard
  • Matthew R Weir
  • Bryce Poolaw
  • Charlton Wilson
  • Mary J Roman
  • Jerome L Fleg
  • Angela Silverman
  • Barbara V Howard

Detail Information

Publications9

  1. ncbi Joint analysis of case-parents trio and unrelated case-control designs in large scale association studies
    Jungnam Joo
    Office of Biostatistics Research, National Heart, Lung and Blood Institute, 6701 Rockledge Drive, MSC 7913, Bethesda, MD 20892 7913, USA
    BMC Proc 1:S28. 2007
    ..The performance of the proposed approaches is examined by analyzing the simulated data provided by the Genetic Analysis Workshop 15...
  2. ncbi Dose finding using the biased coin up-and-down design and isotonic regression
    Mario Stylianou
    Office of Biostatistics Research, National Heart, Lung, and Blood Institute, Bethesda, Maryland 20892, USA
    Biometrics 58:171-7. 2002
    ....
  3. ncbi Estimating the probability of toxicity at the target dose following an up-and-down design
    Mario Stylianou
    Office of Biostatistics Research, National Heart, Lung, and Blood Institute NIH, 6701 Rockledge Drive, Room 8220, Bethesda, MD 20892, U S A
    Stat Med 22:535-43. 2003
    ..We then derive, using bootstrap methods, an estimate of the probability of toxicity at the recommended dose. Small sample properties of this estimator are also evaluated. Published in 2003 by John Wiley & Sons, Ltd...
  4. ncbi The accelerated biased coin up-and-down design in phase I trials
    Mario Stylianou
    Office of Biostatistics Research, NHLBI, Bethesda, Maryland 20892 7938, USA
    J Biopharm Stat 14:249-60. 2004
    ..A simulation study shows that this modification does not adversely affect the precision of the recommended dose, as estimated by isotonic regression, but it does significantly reduce the total time to complete the study...
  5. ncbi Robust ranks of true associations in genome-wide case-control association studies
    Gang Zheng
    Office of Biostatistics Research, National Heart, Lung and Blood Institute, 6701 Rockledge Drive, MSC 7938, Bethesda, Maryland 20892 USA
    BMC Proc 1:S165. 2007
    ..We studied this problem with application to Problem 3 of Genetic Analysis Workshop 15. An independent simulation study was also conducted to further evaluate the proposed procedure...
  6. ncbi Reversible airflow obstruction in lymphangioleiomyomatosis
    Angelo M Taveira-Dasilva
    Translational Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892 1590, USA
    Chest 136:1596-603. 2009
    ..The aims of the present study were to determine the prevalence of reversible airflow obstruction in patients with LAM and to identify associated clinical and physiologic parameters...
  7. ncbi Erythropoietin-driven proliferation of cells with mutations in the tumor suppressor gene TSC2
    Yoshihiko Ikeda
    National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892 1590, USA
    Am J Physiol Lung Cell Mol Physiol 300:L64-72. 2011
    ..Although the high red cell mass of LAM patients could be related to advanced disease, we propose that EPO, synthesized in response to episodic hypoxia, may increase disease progression by enhancing the proliferation of LAM cells...
  8. ncbi Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus
    Angelo M Taveira-Dasilva
    Cardiovascular and Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892 1590, USA
    Ann Intern Med 154:797-805, W-292-3. 2011
    ....
  9. ncbi Examination of lower targets for low-density lipoprotein cholesterol and blood pressure in diabetes--the Stop Atherosclerosis in Native Diabetics Study (SANDS)
    Marie Russell
    Phoenix Indian Medical Center, Phoenix, AZ, USA
    Am Heart J 152:867-75. 2006
    ....